A detailed history of Rise Advisors, LLC transactions in Globus Medical Inc stock. As of the latest transaction made, Rise Advisors, LLC holds 374 shares of GMED stock, worth $30,585. This represents 0.01% of its overall portfolio holdings.

Number of Shares
374
Previous 374 -0.0%
Holding current value
$30,585
Previous $25,000 4.0%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

BUY
$51.15 - $56.52 $15,293 - $16,899
299 Added 398.67%
374 $20,000
Q2 2023

Jul 10, 2023

SELL
$52.61 - $59.54 $2,420 - $2,738
-46 Reduced 38.02%
75 $4,000
Q1 2022

Apr 22, 2022

BUY
$63.68 - $75.54 $1,273 - $1,510
20 Added 19.8%
121 $9,000
Q4 2021

Feb 24, 2022

BUY
$62.62 - $79.92 $6,324 - $8,071
101 New
101 $7.29 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.3B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Rise Advisors, LLC Portfolio

Follow Rise Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rise Advisors, LLC with notifications on news.